Accelerated Approval - Taking the FDA's Concerns Seriously.

Sachs, Rachel E; Donohue, Julie M; Dusetzina, Stacie B

Sachs, Rachel E; Donohue, Julie M; Dusetzina, Stacie B.

Afiliação

Sachs RE; From Washington University in St. Louis School of Law, St. Louis (R.E.S.); the Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh (J.M.D.); and the Department of Health Policy, Vanderbilt University School of Medicine, and the Vanderbilt-Ingram Cancer Center - both in Nashville (S.B.D.).
Donohue JM; From Washington University in St. Louis School of Law, St. Louis (R.E.S.); the Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh (J.M.D.); and the Department of Health Policy, Vanderbilt University School of Medicine, and the Vanderbilt-Ingram Cancer Center - both in Nashville (S.B.D.).
Dusetzina SB; From Washington University in St. Louis School of Law, St. Louis (R.E.S.); the Department of Health Policy and Management, University of Pittsburgh Graduate School of Public Health, Pittsburgh (J.M.D.); and the Department of Health Policy, Vanderbilt University School of Medicine, and the Vanderbilt-Ingram Cancer Center - both in Nashville (S.B.D.).

N Engl J Med ; 387(3): 199-201, 2022 07 21.

Article em En | MEDLINE | ID: mdl-35793197

Assuntos

Aprovação de Drogas; Humanos; Estados Unidos; United States Food and Drug Administration

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Aprovação de Drogas País/Região como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google